comparemela.com

Latest Breaking News On - Pharma limited nasdaq - Page 7 : comparemela.com

OKYO Pharma Today Announces Director Acquires Shares

LONDON and NEW YORK, March 29, 2023 OKYO Pharma Limited , an ophthalmology-focused bio-pharmaceutical company which is developing OK-101 to treat dry eye disease to address the significant. | March 29, 2023

United-kingdom
London
City-of
Robert-emmet
Paul-spencer
Gabriele-cerrone
Garys-jacob
Pharma-limited
Company-adss
Optiva-securities
Panetta-partners
Nasdaq

OKYO Pharma : Director acquires shares - Form 6-K

Director acquires shares London and New York, NY, 29 March, 2023 - OKYO Pharma Limited , an ophthalmology-focused bio-pharmaceutical company which is developing OK-101 to treat. | March 29, 2023

New-york
United-states
United-kingdom
London
City-of
Robert-emmet
Garys-jacob
Paul-spencer
Gabriele-cerrone
Nasdaq
Pharma-limited-nasdaq
London-stock-exchange

vimarsana © 2020. All Rights Reserved.